Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Globus Medical (GMED) Stock Price & Analysis
740 Followers
GMED Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$43.39 - $65.74
Previous Close$63.75
Volume741.83K
Average Volume (3M)1.18M
Market Cap
$8.61B
Enterprise Value$9.08B
Total Cash (Recent Filing)$50.50M
Total Debt (Recent Filing)$520.40M
Price to Earnings (P/E)101.0
Beta1.21
Next Earnings
Aug 01, 2024EPS Estimate
$0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.63
Shares Outstanding135,057,360
10 Day Avg. Volume1,878,489
30 Day Avg. Volume1,181,329
Standard Deviation0.09
R-Squared0.39
Alpha-0.00542
Financial Highlights & Ratios
Price to Book (P/B)5.33
Price to Sales (P/S)13.96
Price to Cash Flow (P/CF)20.90
P/FCF Ratio26.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.79
Enterprise Value/Gross Profit8.90
Enterprise Value/Ebitda24.13
Forecast
1Y Price Target
$67.22Price Target Upside6.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Globus Medical News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst maintains a Buy rating and raises the price target based on strong financial performance and alignment with peer valuations.
Operational EfficiencyManagement's commitment to achieving significant cost synergies and a strong integration of the NuVasive salesforce suggests operational excellence and cost-effective growth.
Product DevelopmentWith the recent launch of 5 new products and ongoing interest from competitive representatives, the company shows a proactive approach to innovation and market expansion.
Bears Say
Financial PerformanceIn the base case scenario, there is a -0.8% downside from the midpoint of 2024 guidance after accounting for dissynergies and cross-selling synergies.
Mergers And AcquisitionsWhile the merger integration remains early days, there is almost no precedent for successful spine M&A, and cultural differences between GMED and NUVA are nothing to underestimate.
Revenue GuidanceFY24 guidance is below Street expectations, implying a conservative or realistic growth outlook.
---
Ownership Overview
14.43% Insiders
38.74% Mutual Funds
45.82% Other Institutional Investors
1.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $43.38 and its highest was $65.74 in the past 12 months.
What is Globus Medical’s market cap?
Currently, no data Available
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Aug 01, 2024 which is in 78 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on May 07, 2024. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.567 by $0.153.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is $0.68.
How many shares outstanding does Globus Medical have?
Globus Medical has 112,624,820 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.72 in its last earnings report, beating expectations of $0.567. Following the earnings report the stock price went up 20.191%.
Which hedge fund is a major shareholder of Globus Medical?
Among the largest hedge funds holding Globus Medical’s share is Fisher Asset Management LLC. It holds Globus Medical’s shares valued at 20M.
---
Globus Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$67.22 (6.97% Upside)
$67.22 (6.97% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 201.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.17%
12-Months-Change
Fundamentals
Return on Equity
2.28%
Trailing 12-Months
Asset Growth
129.98%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
---
GMED Earnings Call
Q1 2024
0:00 / 0:00
---
GMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
---
GMED Stock 12 Month Forecast
Average Price Target
$67.22
▲(6.97% Upside)
Technical Analysis
Best Analysts Covering GMED
1 Year
1 Year Success Rate
20/27 ratings generated profit
1 Year Average Return
+15.72%
reiterated a buy rating 6 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +15.72% per trade.
---